抗酸暴露与间歇性肺部疾病风险之间的关联
Soohyun Bae1, Gjustina Loloci1,2, Dong Yoon Lee1
1Department of Internal Medicine, Myongji Hospital, Hanyang University College of Medicine, Goyang, Republic of Korea.
使用抗酸药物,包括质子抑制剂或H-2抑制剂,与患间歇性肺病 (ILD) 的风险较低有关. 然而,抗酸药与预防异常性肺纤维化 (IPF) 没有显著的关联.
科学领域:
- 肺部病理学 肺部病理学
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 肺纤维化的潜在机制仍然不完全理解.
- 这项研究调查了抗酸药对间歇性肺病 (ILD) 的潜在保护作用.
研究的目的:
- 确定抗酸药的使用,特别是质子抑制剂 (PPI) 和组胺-2受体对抗剂 (H-2抑制剂),是否可以预防ILD的发病.
- 检查抗酸暴露与ILD和异常性肺纤维化 (IPF) 发病率之间的关联.
主要方法:
- 韩国一项基于人口的纵向队列研究 (2006-2010) 包括40岁以上没有先前ILD的成年人.
- 对抗酸药物的暴露 (PPI ± H-2 阻断剂或单独的 H-2 阻断剂) 由治疗持续时间 (> 14 天) 定义.
- 考克斯回归模型分析了抗酸暴露与新的ILD/IPF诊断之间的关联,并对共变量进行调整.
主要成果:
- 抗酸性暴露独立地与患上ILD的风险降低有关 (HR,0.57;p<0.001).
- 抗酸组的ILD发病率为43.2/100,000人/年,而非暴露组的发病率为33.8/100,000人/年.
- 抗酸暴露与IPF的发展没有显著的关联 (HR,0.88;p=0.06).
结论:
- 抗酸使用可能独立地与患间歇性肺病的风险降低有关.
- 这些发现表明抗酸药在ILD中具有潜在的预防作用,但不是特定的IPF.
更多相关视频
09:16Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung Injury
Published on: February 26, 2017
09:29An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing
Published on: May 13, 2020
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Other Disorders of Digestive System
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
